Brain age as an accurate biomarker of preclinical cognitive decline: evidence from a 12-year longitudinal study
{{output}}
Cognitive decline in older adults, particularly during the preclinical stages of Alzheimer's disease (AD), presents a critical opportunity for early detection and intervention. While T1-weighted MRI is widely used in AD research, its capacity to identify earl... ...
